1. Contractors
  2. Ampersand Biosciences LLC

Ampersand Biosciences LLC

Federal contractor · Research and Development in Biotechnology (except Nanobiotechnology)

Ampersand Biosciences has 3 federal contracts of $100,000 or more active since October 2023, with $2.28M obligated, from 1 agency. 2 are still running, 2 ending within 18 months.

Contracts
3 since FY2024$2,281,330 obligated, contracts of $100,000 or more
Running now
2 contracts
Biggest customer
National Institutes of Health$2.28M on 3 contracts
UEI
HLWQXLFM7JR8Unique entity ID in SAM.gov
Source
USAspending.govUpdated Nov 17, 2026, 7:02 PM UTC

Contracts by start year

Obligated so far on contracts active since October 2023, by the fiscal year each started. Fiscal years run Oct 1 to Sep 30.
Show as table
Fiscal yearContracts
FY2022$596,519
FY2024$1,084,824
FY2025$599,987

Running contracts

Soonest end first. An agency may compete the work again, extend the contract or move it to another vehicle.

ContractObligatedEndsState
Further Characterization and Validation of Monoclonal Antibodies to Study RespiratoryNational Institutes of Health · 75N93024C00087$1,084,824Mar 28, 2027in 4 monthsNY
Development of Monoclonal Antibodies to Chemokines in the Ferret Model of Respiratory Disease.National Institutes of Health · 75N93025C00018$599,987May 31, 2027in 6 monthsNY

End dates are the current period of performance; options not yet exercised can extend them. Each contract links to its record on USAspending.gov.

Who they work for

AgencyAmount
National Institutes of Health3 contracts$2,281,330

What they sell

IndustryAmount
Research and Development in Biotechnology (except Nanobiotechnology)NAICS 541714 · 3 contracts$2,281,330

Where the work is

Place of workAmount
New York3 contracts$2,281,330

Source: USAspending.gov, prime contracts of $100,000 or more with an action since October 1, 2023. Department of Defense contracts appear there about 90 days after award. Other contracts ending soon at National Institutes of Health: see the list.

Get new notices like Ampersand Biosciences's work

New contract opportunities under NAICS 541714, research and development in biotechnology (except nanobiotechnology), the morning they appear. Free while in beta.

Free. We use your email only for these alerts and never share it. Privacy